Ticker Details
Dyne Therapeutics, Inc.
IPO Date:	September 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.01B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 3.58%
Avg Daily Range (30 D):	$0.57 | 3.00%
Avg Daily Range (90 D):	$0.61 | 3.42%

Institutional Daily Volume
Avg Daily Volume:	.9M
Avg Daily Volume (30 D):	1.62M
Avg Daily Volume (90 D):	1.63M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	2,600
Avg Institutional Trade:	$2.55M
Avg Institutional Trade (30 D):	$3.32M
Avg Institutional Trade (90 D):	$2.81M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.51M
Avg Closing Trade (30 D):	$7.91M
Avg Closing Trade (90 D):	$6.15M
Avg Closing Volume:	240.67K

News

Jun 26, 2026 @ 3:05 PM Dyne Therapeutics vs. Viking Therapeutics: Which H... Source: Sara Appino

May 30, 2026 @ 4:28 PM Dyne Stock Is Up 56%. Here's What a $14 Million St... Source: Jonathan Ponciano

May 26, 2026 @ 5:00 PM Duchenne Muscular Dystrophy Clinical Trial Pipelin... Source: Delveinsight

May 19, 2026 @ 5:17 PM Dyne Therapeutics Is Up 40%, but One Biotech Fund ... Source: Jonathan Ponciano

Mar 8, 2026 @ 10:01 PM Dyne Therapeutics Announces Initiation of Phase 3 ... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.19	$-.73	$-.73
Diluted EPS	$-3.19	$-.73	$-.73
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-451.71M	$-120.85M	$-111.96M
Operating Income / Loss	$-471.09M	$-125.28M	$-116.13M
Cost of Revenue
Net Cash Flow	$281.29M	$-140.25M	$320.12M
PE Ratio